Evonik and US OPX Biotech to develop renewable specialty chemicals

14 May 2013 14:12  [Source: ICIS news]

LONDON (ICIS)--Germany’s Evonik has formed a joint venture with US-based OPX Biotechnologies (OPXBIO) to developed bio-based specialty chemicals, it said on Tuesday.

The joint venture will use OPXBIO’s proprietary EDGE technology. EDGE, or "Efficiency Directed Genome Engineering", is a technology to develop bio-processes.

Financial, product or capacity details were not disclosed.

By: Stefan Baumgarten
+1 713 525 2653

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly